Phase II Study of Gemcitabine-Paclitaxel 3-Weekly Schedule as First-Line Treatment in Metastatic Breast Cancer After Anthracycline Failure.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 26 Apr 2008 Status changed from in progress to completed.
- 06 Jun 2007 Status changed from recruiting to in progress.
- 27 Apr 2006 New trial record.